Stocklytics Platform

Score (Market)

publish
The Stocklytics Scoring system delivers a well-rounded evaluation, helping investors identify stocks that excel in critical areas. Whether you're focused on value investing, dividend income, or growth potential, our ranking system gives you the clarity needed to make informed investment decisions.
name
arrow_downwardScore languageValue languageQuality languageOwnership languageGrowth languageDividends languagePrice % Change
Asset logo for symbol AUR
AURAurora Innovation
$5.10arrow_drop_up2.10%AI Analysis
Asset logo for symbol FTHM
FTHMFathom Holdings
$2.73arrow_drop_down5.53%AI Analysis
Asset logo for symbol ESTA
ESTAEstablishment Labs Holdings
$40.84arrow_drop_down3.79%AI Analysis
Asset logo for symbol GCTK
GCTKGlucoTrack
$2.46arrow_drop_down7.51%AI Analysis
Asset logo for symbol ARQT
ARQTArcutis Biotherapeutics
$9.59arrow_drop_down5.51%AI Analysis
Asset logo for symbol XLO
XLOXilio Therapeutics
$0.78arrow_drop_up0.73%AI Analysis
EBON
EBONEbang International Holdings
$5.99arrow_drop_up0.25%AI Analysis
Asset logo for symbol MNMD
MNMDMind Medicine
$5.93arrow_drop_down0.67%AI Analysis
Asset logo for symbol PXMD
PXMDPaxMedica
$0.09arrow_drop_down0.20%AI Analysis
Asset logo for symbol BITE
BITEBite Acquisition
$0.54arrow_drop_down3.54%AI Analysis
Asset logo for symbol COOK
COOKTraeger
$3.78arrow_drop_up1.06%AI Analysis
Asset logo for symbol IRBT
IRBTiRobot
$7.23arrow_drop_up0.13%AI Analysis
Asset logo for symbol GDST
GDSTGoldenstone Acquisition Limited
$11.220.00%AI Analysis
Asset logo for symbol CELC
CELCCelcuity
$14.08arrow_drop_down5.15%AI Analysis
Asset logo for symbol GPRO
GPROGoPro
$1.32arrow_drop_up1.53%AI Analysis
Asset logo for symbol PEPG
PEPGPepGen
$9.03arrow_drop_down1.84%AI Analysis
Asset logo for symbol IXHL
IXHLIncannex Healthcare Limited
$2.03arrow_drop_up4.10%AI Analysis
Asset logo for symbol NLSP
NLSPNLS Pharmaceutics AG
$0.14arrow_drop_down6.62%AI Analysis
Asset logo for symbol AKAN
AKANAkanda
$1.14arrow_drop_down1.71%AI Analysis
STHO
STHOStar Holdings - Shares of Beneficial Interest
$13.97arrow_drop_up0.28%AI Analysis
Showing 4341-4360 of 4976
Results per page:

When making investment decisions, a holistic view is essential. The Stocklytics Score provides just that—ranking stocks based on five key factors to give you a comprehensive evaluation. With our Market Score, stocks are ordered by our proprietary scoring system, so you can quickly identify top opportunities. The Stocklytics Score is a powerful combination of: - Value Scoring – Find stocks that offer the best value based on fundamental metrics like price-to-earnings and price-to-sales ratios. - Quality Scoring – Invest with confidence by identifying high-quality companies with strong financials and consistent performance. - Ownership Scoring – Analyze institutional and insider ownership to get a sense of the confidence level from key stakeholders. - Growth Scoring – Discover companies with the potential for above-average earnings and revenue growth. - Dividends Scoring – Focus on stocks with strong dividend yields and sustainable payout ratios for long-term income generation. The Stocklytics Scoring system delivers a well-rounded evaluation, helping investors identify stocks that excel in critical areas. Whether you're focused on value investing, dividend income, or growth potential, our ranking system gives you the clarity needed to make informed investment decisions. Why Use the Stocklytics Score? - Comprehensive View: Assess multiple factors at once to get a balanced perspective. - Data-Driven: Rely on a scoring system built from reliable financial data and market insights. - Actionable Rankings: Prioritize stocks based on their overall score or by individual factors like value or growth.
toolkit image

Discover the Power of Stocklytics Tools

Our suite of tools empowers you to make informed decisions, seize opportunities, and stay ahead in the competitive trading world.

See Stocklytics Tools

Sign up for our newsletter

Join our exclusive community of over one million investment enthusiasts and receive our free newsletter filled with analysis, news, and updates every weekday.

Take Your Investments to a Whole New Level